9 Meters Biopharma Inc banner

9 Meters Biopharma Inc
OTC:NMTRQ

Watchlist Manager
9 Meters Biopharma Inc Logo
9 Meters Biopharma Inc
OTC:NMTRQ
Watchlist
Price: 0.0005 USD Market Closed
Market Cap: $7.2k

During the last 3 months 9 Meters Biopharma Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 400% over this period (open performance analysis).

The last transaction was made on Apr 21, 2023 by Sensenig Bethany , who sold 11k USD worth of NMTRQ shares.

Last Transactions:
Sensenig Bethany
$-11k
Temperato John
$+1.4k
Sirgo Mark A
$+2.1k
Constantino Michael T.
$+380.4
Temperato John
$+1.1k
Sirgo Mark A
$+2.5k
Sirgo Mark A
$+2.5k
Temperato John
$+2.8k
Sirgo Mark A
$+2.2k
Sirgo Mark A
$+1.1k
Temperato John
$+2.6k
Sitar Edward J
$+915
Sirgo Mark A
$+5k
Constantino Michael T.
$+1k
Sirgo Mark A
$+1.4k
Temperato John
$+1.3k
Orbimed Israel Gp Ltd.
$-967.4k
Orbimed Israel Gp Ltd.
$-22k
Orbimed Israel Gp Ltd.
$-57.2k
Temperato John
$+5k
Sitar Edward J
$+2.5k
Sirgo Mark A
$+15k
Temperato John
$+5k
Sitar Edward J
$+2k
Sirgo Mark A
$+7.5k
Sirgo Mark A
$+2.6k
Sirgo Mark A
$+1.5k
Temperato John
$+2.4k
Constantino Michael T.
$+1.3k
Temperato John
$+991.6
Sirgo Mark A
$+2.8k
Temperato John
$+298.5
View All Transactions

During the last 3 months 9 Meters Biopharma Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 400% over this period (open performance analysis).

The last transaction was made on Apr 21, 2023 by Sensenig Bethany , who sold 11k USD worth of NMTRQ shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

9 Meters Biopharma Inc
Insider Trading Chart

9 Meters Biopharma Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

9 Meters Biopharma Inc
Last Insider Transactions

Global
Insiders Monitor

9 Meters Biopharma Inc
Glance View

Market Cap
7.2k USD
Industry
Pharmaceuticals

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on rare and unmet needs in gastroenterology. The company is headquartered in Raleigh, North Carolina and currently employs 21 full-time employees. The company went IPO on 2016-07-08. The firm is focused on developing treatments for people with rare digestive diseases, gastrointestinal (GI) conditions with unmet needs. Its pipeline includes Vurolenatide, Larazotide, NM-102, NM-003, NM-136 and NM-004. Vurolenatide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that combines exenatide with an extended half-life technology for treatment of short bowel syndrome (SBS). Larazotide is an 8-amino acid peptide formulated into an orally administered capsule for treatment of celiac disease. NM-102 is a small molecule peptide, is being developed as a potential microbiome modulator and is undergoing an indication selection process. NM-003 is a long-acting GLP-2 receptor agonist, for prevention of acute graft versus host disease. NM-004 is a double-cleaved mesalamine with an immunomodulator for pediatric ulcerative colitis.

NMTRQ Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett